Rami S. Komrokji, MD, principal investigator, MDS Research Consortium,
Ramesh Balusu, Ph.D., one of our researchers at The University of Kansas Cancer Center, is working to uncover what happens behind the scenes leading to the development of certain types of blood cancers like acute myeloid leukemia.
Thanks to recent advances in genetic analysis techniques, scientists studying how genetic mutations impact the progression of
This multicenter study, which began in 2013, was led by Dr. Eytan Stein at Memorial Sloan Kettering Cancer Center in New York, NY. Its purpose was to evaluate the safety and efficacy of orally administered AG-221 (Enasidenib) in subjects with advanced Acute Myeloid Leukemia (AML) that harbor an IDH2
The recent emergence of targeted therapies has revolutionized the understanding and treatment of some